Antonin Saldmann
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 4
-
- Immunotherapy and Immune Responses 3
- Co-authors
- Éric Tartour (7 shared papers)Clémence Granier (5 shared papers)Charlotte Blanc (3 shared papers)Éléonore De Guillebon (3 shared papers)Stéphane Oudard (3 shared papers)Alain Gey (3 shared papers)Hélène Roussel (2 shared papers)Cécile Badoual (2 shared papers)
- Journals
- Gene (1 paper)ESMO Open (1 paper)OncoImmunology (1 paper)International Journal of Cancer (1 paper)Seminars in Immunopathology (1 paper)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Antonin Saldmann
9 papers receiving 402 citations
Peers
Comparison fields: 5 of 58
- Oncology 298
- Immunology 205
- Pulmonary and Respiratory Medicine 73
- Genetics 21
- Cancer Research 25
Countries citing papers authored by Antonin Saldmann
This map shows the geographic impact of Antonin Saldmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonin Saldmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonin Saldmann more than expected).
Fields of papers citing papers by Antonin Saldmann
This network shows the impact of papers produced by Antonin Saldmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonin Saldmann. The network helps show where Antonin Saldmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Antonin Saldmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 252 | |
| 2 | 2018 | 63 | |
| 3 | 2020 | 47 | |
| 4 | 2023 | 21 | |
| 5 | 2018 | 15 | |
| 6 | 2018 | 5 | |
| 7 | 2020 | 3 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 1 |
About Antonin Saldmann
Antonin Saldmann is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Surgery and Cardiology and Cardiovascular Medicine, having authored 9 papers that have together received 409 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (3 papers), Renal cell carcinoma treatment (2 papers), Cancer Genomics and Diagnostics (1 paper), Graphene and Nanomaterials Applications (1 paper), Cardiovascular Disease and Adiposity (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Oncology (298 citations), Immunology (205 citations), Pulmonary and Respiratory Medicine (73 citations), Genetics (21 citations) and Cancer Research (25 citations). Antonin Saldmann has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Éric Tartour, Clémence Granier, Charlotte Blanc, Éléonore De Guillebon, Stéphane Oudard, Alain Gey, Hélène Roussel, Cécile Badoual, Thi Tran and Corinne Tanchot. Their work appears in journals such as Gene, ESMO Open, OncoImmunology, International Journal of Cancer and Seminars in Immunopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.